Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:March 7, 2024Not yet recruiting